News1 min ago
Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic
More Patients Added to Phase 1 Trial Following Encouraging Early Results ROCHESTER, Minn., June 14, 2023 /PRNewswire/ — Vyriad, Inc., announces an expansion of a Phase 1...
